Amiloidózis: nyitott vizsgálatok itt: Dél-Korea

• NCT06128629

  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Kísérleti kezelés · 3. fázis · Intellia Therapeutics

  Chonnam National University Hospital, Gwangju · Seoul National University Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul

  Regiszter frissítve: 2026-11-04

• NCT06679946

  A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Kísérleti kezelés · 3. fázis · Alnylam Pharmaceuticals

  Seoul

  Regiszter frissítve: 2026-10-21

• NCT07207811

  CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis

  Kísérleti kezelés · 3. fázis · Novo Nordisk A/S

  Inje University Haeundae Paik Hospital, Busan · Seoul National University Bundang Hospital (SNUBH), Seongnam-si · The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul · Samsung Medical Center, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul National University Hospital, Seoul

  Regiszter frissítve: 2026-10-21

• NCT07052903

  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Kísérleti kezelés · 3. fázis · Alnylam Pharmaceuticals

  Incheon · Seoul

  Regiszter frissítve: 2026-10-20

• NCT07223203

  TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  Kísérleti kezelés · 3. fázis · Alnylam Pharmaceuticals

  Seoul

  Regiszter frissítve: 2026-10-08

• NCT07789483

  An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy

  Kísérleti kezelés · 3. fázis · Alexion Pharmaceuticals, Inc.

  Busan · Seoul

  Regiszter frissítve: 2026-08-28

• NCT06292780

  A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

  Kísérleti kezelés · 1/2. fázis · Regeneron Pharmaceuticals

  Samsung Medical Center, Seoul · Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul · Seoul National University Hospital, Seoul · Asan Medical Center, Seoul

  Regiszter frissítve: 2026-08-18

• NCT06563895

  Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

  Kísérleti kezelés · 3. fázis · Eidos Therapeutics, a BridgeBio company

  Seoul National University Hospital, Seoul · Severance Hospital, Yonsei University Health System, Seoul · Seoul St. Mary's Hospital, Seoul · Samsung Medical Center, Seoul

  Regiszter frissítve: 2026-08-04

• NCT07567508

  Early Detection of Concealed Cardiac Amyloidosis Using AI-ECG and CT-Derived Extracellular Volume in Patients With Atrial Fibrillation

  Kísérleti kezelés · Samsung Medical Center

  Samsung Medical Center, Seoul

  Regiszter frissítve: 2026-05-05

• NCT02798705

  Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis

  Kutatás · Samsung Medical Center

  Samsung Medical Center, Seoul

  Regiszter frissítve: 2025-03-14

Minden vizsgálat (Amiloidózis) és a térkép

Ez az oldal nem orvosi tanács. Mielőtt egy vizsgálatot megkeresel, beszélj az orvosoddal.

Hibát jelzek